TORONTO, Jan. 16, 2018 /CNW/ - Nuuvera Inc. ("Nuuvera")
(TSXV: NUU) is proud to announce it is entering into a joint
partnership with Globalive Technology Partners (GTP) to bring
blockchain technology to the global cannabis market.
Following the joint development of the blockchain technology,
both Nuuvera and GTP will license the software around the globe to
help increase the safety and security of records as well as help
supply chain management globally.
The first of its kind partnership will see Nuuvera and GTP
developing proprietary blockchain technology that will help
validate the integrity and grade of cannabis products,
from source to consumer.
"We're extremely excited to partner with Anthony Lacavera and GTP on this disruptive
global cannabis technology. In applying blockchain technology
to this emerging industry, we will continue to shape the global
cannabis market, and set an incredibly high bar for safety and
consistency that will benefit patients everywhere," said Nuuvera
CEO, Lorne Abony.
"Nuuvera's mission is to lead the emerging cannabis industry by
developing safe, consistent, and effective products for patients.
We are already leveraging the capabilities of our global network
with an aim of becoming the most innovative cannabis company in the
world. Through this partnership with GTP, we can use blockchain
technology to ensure the integrity and grade of our products – from
source to retail. This demonstrates our deep commitment to leading
the global cannabis industry in a positive and meaningful way,"
Lorne continued.
GTP – who announced last week they will go public in 2018 -- is
forming partnerships with a very select group of leading companies
across a variety of sectors who recognize the strategic advantage
of incorporating blockchain into their sectors. GTP have selected
Nuuvera as the sole partner for the emerging and burgeoning global
cannabis market.
Anthony Lacavera, co-founder and
CEO of GTP stated, "At GTP we share Nuuvera's vision to help build
an innovative and safe global cannabis market. We also want to see
consumers receive the safest, highest quality products. That's why
we are delighted to choose Nuuvera as our sole partner to bring
machine intelligence and blockchain technology to the cannabis
industry."
For more information on Nuuvera, please visit:
www.nuuvera.com
About Nuuvera
Nuuvera is a global cannabis company founded on Canadian
principles, and built with the whole world in mind. Nuuvera is
currently working with partners in Germany, Israel and Italy, and is exploring opportunities in
several other countries, to develop commercial production and
global distribution of medical grade cannabis in legalized markets.
Through its subsidiaries, ARA – Avanti Rx Analytics Inc. and Avalon
Pharmaceutical Inc., Nuuvera holds a Dealer License (GMP) under the
Narcotic Control Regulations and Office of Controlled Substances.
Nuuvera is currently in the final stages of the Health Canada
review process to become a Licensed Producer of medical marijuana
under the ACMPR, and has recently received its "letter to build"
approval.
Notice regarding forward-looking statements:
This release includes forward-looking statements regarding
Nuuvera and its business. Often, but not always, forward-looking
statements can be identified by the use of words such as "plans",
"is expected", "expects", "scheduled", "intends", "contemplates",
"anticipates", "believes", "proposes" or variations (including
negative variations) of such words and phrases, or state that
certain actions, events or results "may", "could", "would", "might"
or "will" be taken, occur or be achieved. Such statements are based
on the current expectations of the management of Nuuvera. The
forward-looking events and circumstances discussed in this release
may not occur by certain specified dates or at all and could differ
materially as a result of known and unknown risk factors and
uncertainties affecting Nuuvera, including risks regarding the
cannabis industry, failure to obtain regulatory approvals, economic
factors, the equity markets generally and risks associated with
growth and competition. Although Nuuvera has attempted to identify
important factors that could cause actual actions, events or
results to differ materially from those described in
forward-looking statements, there may be other factors that cause
actions, events or results to differ from those anticipated,
estimated or intended. No forward-looking statement can be
guaranteed. Except as required by applicable securities laws,
forward-looking statements speak only as of the date on which they
are made Nuuvera undertakes no obligation to publicly update or
revise any forward-looking statement, whether as a result of new
information, future events, or otherwise.
Neither the TSX Venture Exchange nor its Regulation Service
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release. The TSX Venture Exchange has in no way
passed upon the merits of the transaction and has neither approved
nor disapproved the content of this press release.
SOURCE Nuuvera Inc.